Gene Therapy for DME

Summary

The goal of this clinical trial is to evaluate the safety, tolerability and efficacy of disposable vitreous injection of FT-003 in subjects with Diabetic Macular Edema (DME). The study was divided into two phases, Phase 1 dose escalation and Phase II dose expansion.

Timeline

Start

2023-11-15

Primary completion

2024-11-15

Completion

2028-11-15

Drugs

Indications